TrialFuture oncology (London, England)2016

ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma.

Grzegorz S Nowakowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.